Status:
COMPLETED
Prevention of Broncho-aspiration (BA) in Adult Subjects During Their ICU Stay
Lead Sponsor:
Marshall University
Conditions:
Bronchial Aspiration
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patients of age \>18 yo, admitted to the ICU through the surgery department from 2AUG2021 to 1AUG2022 will be divided into three groups: 1. Patients admitted to the ICU in the first 3-4 months will h...
Eligibility Criteria
Inclusion
- Age\>18
- All the patients admitted to ICU by surgery department.
- Development of aspiration pneumonia in patients admitted to ICU department of VA hospital.
- Aspiration Pneumonia development during hospital stay and treating physician indicated the diagnosis of aspiration pneumonia in history and physical exam notes.
Exclusion
- Age \<18
- Patient transferred or admitted to the hospital as a primary diagnosis of aspiration pneumonia (development of aspiration pneumonia prior to admission).
- Treating physician not documented aspiration pneumonia in history or physical exam notes.
- Drug overdose, seizure or cardiopulmonary arrest prior to hospital admission.
Key Trial Info
Start Date :
August 3 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 2 2021
Estimated Enrollment :
159 Patients enrolled
Trial Details
Trial ID
NCT05284084
Start Date
August 3 2021
End Date
November 2 2021
Last Update
April 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Marshall University School of Medicine
Huntington, West Virginia, United States, 25701